SCHEMBL24757358

SCHEMBL24757358

CS(=O)(=O)c1cccc(NC(=O)c2c(C(F)(F)F)cnn2CC2CCCOC2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
ELANE P08246 3/20 0.39
KLKB1 P03952 1/20 0.37
CARM1 Q86X55 1/20 0.37
IRAK4 Q9NWZ3 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CREBBP Q92793 2/20 0.37
BRD4 O60885 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
RAF1 P04049 1/20 0.36
BRAF P15056 1/20 0.36
DHODH Q02127 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30107048 1.00 NR1H2 (0.41) NR1H2AKR1C3AKR1C2ELANEKLKB1
SCHEMBL24758199 0.91 AKR1C3 (0.47) AKR1C3AKR1C2KLKB1CARM1IRAK4
SCHEMBL24758197 0.91 AKR1C3 (0.47) AKR1C3AKR1C2KLKB1CARM1IRAK4
SCHEMBL24758193 0.90 AKR1C3 (0.45) NR1H2AKR1C3AKR1C2KLKB1CARM1
SCHEMBL30141424 0.90 AKR1C3 (0.45) NR1H2AKR1C3AKR1C2KLKB1CARM1
SCHEMBL24906371 0.90 AKR1C3 (0.47) AKR1C3AKR1C2KLKB1CARM1KDM4E
SCHEMBL24906379 0.90 AKR1C3 (0.47) AKR1C3AKR1C2KLKB1CARM1KDM4E
SCHEMBL24757352 0.85 NR1H2 (0.41) NR1H2AKR1C3AKR1C2ELANEKLKB1
SCHEMBL24758196 0.85 AKR1C3 (0.41) AKR1C3AKR1C2KLKB1CARM1CREBBP
SCHEMBL30141321 0.85 AKR1C3 (0.41) AKR1C3AKR1C2KLKB1CARM1CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES GRUENENTHAL GMBH (DE) 2023-01-26 US disclosed
WO-2022263498-A1 SUBSTITUTED PYRAZOLE AMIDES Grünenthal GmbH (DE) 2022-12-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230025025-A1 SUBSTITUTED PYRAZOLE AMIDES SCN8A, SCN1A, SCN7A NR1H2 1438/4885AKR1C3 1950/4885AKR1C2 1995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.